NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.210
+0.120 (11.01%)
Dec 5, 2025, 4:00 PM EST - Market closed
NovaBay Pharmaceuticals Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $0.85 | Strong Buy | Maintains | $8 → $0.85 | -29.75% | Nov 11, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5,206 → $4,900 | Strong Buy | Maintains | $5,206 → $4,900 | +404,858.68% | May 20, 2022 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 26, 2018 |
| Roth Capital | Roth Capital | Strong Buy Initiates $193 | Strong Buy | Initiates | $193 | +15,809.09% | Jun 5, 2017 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $68,906 | Strong Buy | Initiates | $68,906 | +5,694,631.40% | Mar 6, 2013 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $68,906 | Strong Buy | Initiates | $68,906 | +5,694,631.40% | Mar 5, 2013 |